Sleep apnoeas may represent a reversible risk factor for amyloid-β pathology

Brain. 2017 Dec 1;140(12):e75. doi: 10.1093/brain/awx281.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Amyloid beta-Peptides / cerebrospinal fluid*
  • Biomarkers / cerebrospinal fluid
  • Continuous Positive Airway Pressure / methods
  • Humans
  • Male
  • Middle Aged
  • Peptide Fragments / cerebrospinal fluid*
  • Polysomnography / methods
  • Risk Factors
  • Sleep Apnea Syndromes / cerebrospinal fluid*
  • Sleep Apnea Syndromes / diagnostic imaging*
  • Sleep Apnea Syndromes / therapy
  • Sleep Stages / physiology

Substances

  • Amyloid beta-Peptides
  • Biomarkers
  • Peptide Fragments
  • amyloid beta-protein (1-40)
  • amyloid beta-protein (1-42)